Viewing Study NCT03636906


Ignite Creation Date: 2025-12-26 @ 2:43 PM
Ignite Modification Date: 2026-01-26 @ 11:42 AM
Study NCT ID: NCT03636906
Status: COMPLETED
Last Update Posted: 2022-07-27
First Post: 2018-08-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV
Sponsor: GlaxoSmithKline
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-04-08
Start Date Type: ACTUAL
Primary Completion Date: 2020-01-16
Primary Completion Date Type: ACTUAL
Completion Date: 2021-07-22
Completion Date Type: ACTUAL
First Submit Date: 2018-08-16
First Submit QC Date: None
Study First Post Date: 2018-08-17
Study First Post Date Type: ACTUAL
Results First Submit Date: 2022-05-13
Results First Submit QC Date: None
Results First Post Date: 2022-07-27
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-07-05
Last Update Post Date: 2022-07-27
Last Update Post Date Type: ACTUAL